Drreddys Laboratories | RDY - Stammkapital





Stammkapital Veränderung Datum
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Aurora Cannabis CAD 58.95M 2.24M 2026-03
Bayer EUR 982.42M 0 2026-06
Canopy Growth CAD 422.07M 53.78M 2026-03
Cipla INR 807.78M 17K 2026-03
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Drreddys Laboratories INR 832.69M 123K 2026-03
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Lonza CHF 68.64M 0 2025-12
Novartis USD 1.9B 7.38M 2026-06
Pacira USD 39.82M 512K 2026-06
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 47.37M 53K 2026-06
Richter Gedeon HUF 182.86M 3.51M 2026-03
Sun Pharmaceuticals INR 2.4B 0 2026-03
Supernus Pharmaceuticals USD 58.16M 124K 2026-06
Teva Pharmaceutical Industries USD 1.16B 1000K 2026-06